Findings
========

*Escherichia coli* producing extended-spectrum β-lactamases (ESBLs) is a challenge for clinical treatment and infection control. *bla*~CTX-M-15~ has emerged as the most widely distributed gene encoding ESBLs globally, but it was not common in China \[[@B1]\]. We performed a snapshot survey on the molecular epidemiology of *E. coli* carrying *bla*~CTX-M-15~ in Sichuan province, western China.

All non-duplicated *E. coli* clinical isolates (n = 144) that were recovered in 20 hospitals in Sichuan, western China, from June 22 to 25, 2011 were collected regardless of their antimicrobial susceptibility profiles and types of infections. The presence of *bla*~CTX-M~ genes were detected using both a single PCR with universal primers CTX-U1/U2 and a multiplex PCR \[[@B2],[@B3]\] and 25.7% (37/144) isolates were found carrying *bla*~CTX-M~. A total of 17 isolates had a *bla*~CTX-M~ gene belonging to the *bla*~CTX-M-1~ group and the complete sequence of the *bla*~CTX-M-1~-like gene in all 17 isolates was obtained using PCR with primers ISEcp1IR-F and orf477-R \[[@B4]\]. Sequencing revealed *bla*~CTX-M-15~ in 8 isolates, corresponding to 21.6% of *bla*~CTX-M~ variants, and the remaining 9 isolates had either *bla*~CTX-M-55~ (n = 8) or *bla*~CTX-M-57~ (n = 1). The 8 isolates carrying *bla*~CTX-M-15~ were from urine (n = 5), sputum (n = 2) and ascites (Table [1](#T1){ref-type="table"}). Although *bla*~CTX-M-15~ has become the dominant gene encoding ESBLs in many countries and *E. coli* of ST131 carrying *bla*~CTX-M-15~ was widely distributed \[[@B5]\], *bla*~CTX-M-15~ had only been occasionally found in isolates recovered before 2007 in China \[[@B1]\]. However, several studies on *E. coli* isolates obtained in 2007 and afterwards in China have found that *bla*~CTX-M-15~ accounted to 14% to 24% of *bla*~CTX-M~ variants detected from human \[[@B6],[@B7]\]. The present study and previous reports therefore suggested the emergence of *E. coli* carrying *bla*~CTX-M-15~ in China in recent 5 years.

###### 

**Molecular characteristics of 8*E. coli*isolates carrying*bla***~**CTX-M-15**~

  **Isolate**   **Source**   **ST**   **Phylogenetic group**   **Inc group**^**1**^   **pMLST/RST**^**1**^   **Additional resistance genes**^**3**^
  ------------- ------------ -------- ------------------------ ---------------------- ---------------------- -------------------------------------------------------
  A63           urine        3513     A                        FIIA                   F31:A-:B-              ***bla***~**TEM**~**,***aac (3)-II*
  H9            urine        3342     D                        FIIA FIA FIB           F1:A2:B1               ***bla***~**TEM**~**,***aac (3)-II*, *aac (6′)-Ib*-cr
  D57           urine        3516     B2                       FIIA FIA FIB           F1:A2:B20              ***bla***~**TEM**~**,***aac (3)-II*
  W19           urine        131      B2                       FIIA                   F2:A-:B-               ***bla***~**TEM**~**,***qnrS*
  V12           sputum       3518     B2                       I1                     1-ND^2^-10-ND^2^-6      
  I10           sputum       3517     B2                       I1                     ST16 (1-5-10-8-6)      ***bla***~**TEM**~**,***aac (3)-II*
  U35           urine        131      B2                       I1                     ST16 (1-5-10-8-6)      *qnrS*
  I20           ascites      131      B2                       I1                     ST16 (1-5-10-8-6)      *aac (3)-II*

^1^Inc, incompatibility; Inc group and pMLST/RST results are for plasmids carrying *bla*~CTX-M-15~.

The allele number of the IncI1 pMLST profile (*repI*, *ardA*, *trbA*, *sogS* and *pill*) is indicated.

^2^ND, not determined.

^3^Resistance genes that were co-transferred with *bla*~CTX-M-15~ are in bold.

Six of the isolates carrying *bla*~CTX-M-15~ belonged to the phylogenetic group B2 and the remaining two were of group A1 and D, respectively, determined as described previously \[[@B8]\] (Table [1](#T1){ref-type="table"}). Using multi-locus sequence typing (MLST) \[[@B9]\], the 8 isolates carrying *bla*~CTX-M-15~ were assigned to 6 sequence types (ST) including ST131 and 5 new STs (Table [1](#T1){ref-type="table"}). Of note, *E. coli* of ST131 was found carrying *bla*~CTX-M-3~, ~-14~ and ~-65~ but not ~-15~ in our local settings previously \[[@B10]\]. This study demonstrated the emergence of the globally-spread ST131 carrying *bla*~CTX-M-15~ in our region. The 5 new STs (ST3342, ST3513, ST3516, ST3517 and ST3518) shared 5 identical alleles (*gyrB*, *icd*, *mdh*, *purA* and *recA*) out of 7 and these STs might therefore belong to a common clonal complex. In contrast, the 5 STs had only up to 2 alleles identical to ST131, suggesting the 5 STs and ST131 had different clonal origins.

Self-transmissible plasmids carrying *bla*~CTX-M-15~ were obtained from 7 out of the 8 isolates using mating as described previously \[[@B4]\]. The remaining isolate V12 did not yield transconjugants carrying *bla*~CTX-M-15~ despite repeated attempts but transformants carrying *bla*~CTX-M-15~ were obtained from V12 by electroporation with plasmids prepared using alkaline lysis \[[@B11]\]. This suggests that *bla*~CTX-M-15~ was carried by a non-conjugative plasmid in isolate V12. Plasmids carrying *bla*~CTX-M-15~ were prepared using alkaline lysis and were subjected to PCR-based replicon typing \[[@B12]\]. Four plasmids were of IncI1 and the other four belonged to the IncFII-related group, two of which contained replicons of IncFIA and IncFIB in addition to the IncFII-related replicon. IncF plasmid replicons sequence typing (RST) \[[@B13]\] and IncI1 plasmid MLST (pMLST) \[[@B14]\] were employed to investigate the relatedness of these plasmids carrying *bla*~CTX-M-15~ (Table [1](#T1){ref-type="table"}). All of the IncI1 plasmids except the non-conjugative one from isolate V12 were of ST16 (1-5-10-8-6). According to the IncI1 pMLST database (<http://pubmlst.org/plasmid/>), ST16 IncI1 plasmids have been found carrying *bla*~CTX-M-15~ in isolates from cattle in the UK but were not found in human isolates carrying *bla*~CTX-M-15~ before. The identification of ST16 IncI1 plasmids in both cattle and human isolates suggested the transfer of *bla*~CTX-M-15~ between animal and human, which implicates that the control of the transmission of *bla*~CTX-M-15~ should address sources beyond human. Two alleles, *ardA* and *sogS*, both of which are associated with conjugation, were unable to be amplified from the non-conjugative plasmid (pV12) carrying *bla*~CTX-M-15~ from isolate V12. Therefore, the ST could not be assigned for pV12 but the remaining three alleles of pV12 were identical to those of ST16, suggesting that pV12 might be derived from a ST16 IncI1 plasmid. Four different RST profiles were present for the four IncF plasmids carrying *bla*~CTX-M-15~, suggesting that the spread of *bla*~CTX-M-15~ in our local settings might have been mediated by multiple IncF plasmids. Among the four RST types of IncF plasmids identified here, F2:A-:B- plasmids carrying *bla*~CTX-M-15~ appeared to be widely distributed and have been found in Canada, France, Italy and the UK (<http://pubmlst.org/plasmid/>), while the remaining three types, F1:A2:B1, F1:A2:B20 and F31:A-:B- have not been deposited in the RST database, representing new IncF RST types.

The co-transfer of a few antimicrobial resistance genes including *qnrA*, *qnrB*, *qnrS*, *qepA*, *aac(6′)-Ib*-cr, *aac(3)-II*, *tetA*, *bla*~TEM~ and *bla*~OXA-1~ with *bla*~CTX-M-15~ were examined for transconjugants and transformants by PCR. Unlike previous studies, the co-transfer of resistance genes with *bla*~CTX-M-15~ except for *bla*~TEM-1~ was not common in this study (Table [1](#T1){ref-type="table"}).

In summary, although *bla*~CTX-M-14~ was the most common *bla*~CTX-M~ variant in China, the present study together with recent reports \[[@B6],[@B7]\] suggested that *bla*~CTX-M-15~ has emerged in China. The prevalence of *bla*~CTX-M-15~-carrying isolates would compromise the efficacy of the widely-used broad-spectrum cephalosporins and therefore represents a serious challenge for clinical treatment and public health. The spread of *bla*~CTX-M-15~ in our local settings is mediated by two clonal complexes and by self-transmissible plasmids of IncI1 or IncF. The spread of isolates carrying *bla*~CTX-M-15~ in China warrants more studies. The interruption of both vertical and horizontal transmission of *bla*~CTX-M-15~ using infection control measures such as standard precautions and contact precautions appear to be the key to hurdle the further spread of this antimicrobial resistance determinant.
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